nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetylsalicylic acid—NFKBIA—breast cancer	0.246	0.546	CbGaD
Acetylsalicylic acid—TP53—breast cancer	0.109	0.242	CbGaD
Acetylsalicylic acid—PTGS1—breast cancer	0.0372	0.0827	CbGaD
Acetylsalicylic acid—PTGS2—breast cancer	0.0213	0.0473	CbGaD
Acetylsalicylic acid—SLC22A7—Fluorouracil—breast cancer	0.0199	0.0814	CbGbCtD
Acetylsalicylic acid—ALB—breast cancer	0.019	0.0421	CbGaD
Acetylsalicylic acid—ABCB1—breast cancer	0.0181	0.0402	CbGaD
Acetylsalicylic acid—CYP2C9—Anastrozole—breast cancer	0.0158	0.0646	CbGbCtD
Acetylsalicylic acid—SLC22A7—Docetaxel—breast cancer	0.0152	0.0622	CbGbCtD
Acetylsalicylic acid—CYP2C8—Lapatinib—breast cancer	0.0151	0.0618	CbGbCtD
Acetylsalicylic acid—ABCB1—Toremifene—breast cancer	0.014	0.0573	CbGbCtD
Acetylsalicylic acid—CYP2C19—Lapatinib—breast cancer	0.0127	0.0518	CbGbCtD
Acetylsalicylic acid—CYP2C9—Idarubicin—breast cancer	0.012	0.0489	CbGbCtD
Acetylsalicylic acid—CYP2C8—Raloxifene—breast cancer	0.0115	0.0468	CbGbCtD
Acetylsalicylic acid—SLC22A7—Methotrexate—breast cancer	0.011	0.0449	CbGbCtD
Acetylsalicylic acid—ABCB1—Lapatinib—breast cancer	0.0102	0.0418	CbGbCtD
Acetylsalicylic acid—CYP2C8—Tamoxifen—breast cancer	0.00757	0.0309	CbGbCtD
Acetylsalicylic acid—ALB—Irinotecan—breast cancer	0.00752	0.0307	CbGbCtD
Acetylsalicylic acid—ALB—Fluorouracil—breast cancer	0.00722	0.0295	CbGbCtD
Acetylsalicylic acid—CYP2C9—Capecitabine—breast cancer	0.00656	0.0268	CbGbCtD
Acetylsalicylic acid—CYP2C19—Tamoxifen—breast cancer	0.00635	0.0259	CbGbCtD
Acetylsalicylic acid—CYP2C8—Paclitaxel—breast cancer	0.00589	0.0241	CbGbCtD
Acetylsalicylic acid—ABCB1—Vinorelbine—breast cancer	0.00568	0.0232	CbGbCtD
Acetylsalicylic acid—CYP2C8—Fluorouracil—breast cancer	0.00558	0.0228	CbGbCtD
Acetylsalicylic acid—CYP2C9—Tamoxifen—breast cancer	0.00528	0.0216	CbGbCtD
Acetylsalicylic acid—ABCB1—Tamoxifen—breast cancer	0.00512	0.0209	CbGbCtD
Acetylsalicylic acid—ABCB1—Mitoxantrone—breast cancer	0.005	0.0204	CbGbCtD
Acetylsalicylic acid—SLC22A6—Methotrexate—breast cancer	0.00467	0.0191	CbGbCtD
Acetylsalicylic acid—ABCB1—Gemcitabine—breast cancer	0.00441	0.018	CbGbCtD
Acetylsalicylic acid—CYP2C9—Paclitaxel—breast cancer	0.00411	0.0168	CbGbCtD
Acetylsalicylic acid—ABCB1—Paclitaxel—breast cancer	0.00399	0.0163	CbGbCtD
Acetylsalicylic acid—ALB—Methotrexate—breast cancer	0.00398	0.0163	CbGbCtD
Acetylsalicylic acid—ABCB1—Irinotecan—breast cancer	0.00394	0.0161	CbGbCtD
Acetylsalicylic acid—CYP2C9—Fluorouracil—breast cancer	0.00389	0.0159	CbGbCtD
Acetylsalicylic acid—ABCB1—Vinblastine—breast cancer	0.0035	0.0143	CbGbCtD
Acetylsalicylic acid—TP53—arm—breast cancer	0.00345	0.0564	CbGeAlD
Acetylsalicylic acid—ABCB1—Docetaxel—breast cancer	0.00288	0.0118	CbGbCtD
Acetylsalicylic acid—ABCB1—Doxorubicin—breast cancer	0.00215	0.00878	CbGbCtD
Acetylsalicylic acid—ABCB1—Methotrexate—breast cancer	0.00208	0.0085	CbGbCtD
Acetylsalicylic acid—TP53—mammary gland—breast cancer	0.00151	0.0246	CbGeAlD
Acetylsalicylic acid—HSPA5—mammary gland—breast cancer	0.00145	0.0237	CbGeAlD
Acetylsalicylic acid—TP53—nipple—breast cancer	0.00125	0.0204	CbGeAlD
Acetylsalicylic acid—RPS6KA3—mammary gland—breast cancer	0.00124	0.0202	CbGeAlD
Acetylsalicylic acid—NFKBIA—nipple—breast cancer	0.00123	0.0201	CbGeAlD
Acetylsalicylic acid—HSPA5—nipple—breast cancer	0.0012	0.0196	CbGeAlD
Acetylsalicylic acid—TP53—embryo—breast cancer	0.00103	0.0168	CbGeAlD
Acetylsalicylic acid—RPS6KA3—nipple—breast cancer	0.00102	0.0167	CbGeAlD
Acetylsalicylic acid—NFKBIA—embryo—breast cancer	0.00101	0.0165	CbGeAlD
Acetylsalicylic acid—EDNRA—mammary gland—breast cancer	0.00101	0.0164	CbGeAlD
Acetylsalicylic acid—HSPA5—embryo—breast cancer	0.000993	0.0162	CbGeAlD
Acetylsalicylic acid—RPS6KA3—embryo—breast cancer	0.000846	0.0138	CbGeAlD
Acetylsalicylic acid—TP53—epithelium—breast cancer	0.000841	0.0137	CbGeAlD
Acetylsalicylic acid—EDNRA—nipple—breast cancer	0.000833	0.0136	CbGeAlD
Acetylsalicylic acid—NFKBIA—epithelium—breast cancer	0.000827	0.0135	CbGeAlD
Acetylsalicylic acid—HSPA5—epithelium—breast cancer	0.00081	0.0132	CbGeAlD
Acetylsalicylic acid—TP53—skin of body—breast cancer	0.0008	0.0131	CbGeAlD
Acetylsalicylic acid—NFKBIA—skin of body—breast cancer	0.000787	0.0128	CbGeAlD
Acetylsalicylic acid—HSPA5—skin of body—breast cancer	0.000771	0.0126	CbGeAlD
Acetylsalicylic acid—IKBKB—nipple—breast cancer	0.000757	0.0124	CbGeAlD
Acetylsalicylic acid—TP53—endometrium—breast cancer	0.000754	0.0123	CbGeAlD
Acetylsalicylic acid—NFKBIA—endometrium—breast cancer	0.000742	0.0121	CbGeAlD
Acetylsalicylic acid—HSPA5—endometrium—breast cancer	0.000726	0.0119	CbGeAlD
Acetylsalicylic acid—TP53—uterus—breast cancer	0.000695	0.0113	CbGeAlD
Acetylsalicylic acid—NFKBIA—uterus—breast cancer	0.000684	0.0112	CbGeAlD
Acetylsalicylic acid—TP53—pituitary gland—breast cancer	0.000682	0.0111	CbGeAlD
Acetylsalicylic acid—TP53—adipose tissue—breast cancer	0.00068	0.0111	CbGeAlD
Acetylsalicylic acid—NFKBIA—pituitary gland—breast cancer	0.000671	0.011	CbGeAlD
Acetylsalicylic acid—HSPA5—uterus—breast cancer	0.000669	0.0109	CbGeAlD
Acetylsalicylic acid—NFKBIA—adipose tissue—breast cancer	0.000668	0.0109	CbGeAlD
Acetylsalicylic acid—HSPA5—pituitary gland—breast cancer	0.000657	0.0107	CbGeAlD
Acetylsalicylic acid—HSPA5—adipose tissue—breast cancer	0.000655	0.0107	CbGeAlD
Acetylsalicylic acid—TP53—female reproductive system—breast cancer	0.000625	0.0102	CbGeAlD
Acetylsalicylic acid—IKBKB—embryo—breast cancer	0.000624	0.0102	CbGeAlD
Acetylsalicylic acid—RPS6KA3—endometrium—breast cancer	0.000619	0.0101	CbGeAlD
Acetylsalicylic acid—NFKBIA—female reproductive system—breast cancer	0.000614	0.01	CbGeAlD
Acetylsalicylic acid—TP53—adrenal gland—breast cancer	0.00061	0.00995	CbGeAlD
Acetylsalicylic acid—HSPA5—female reproductive system—breast cancer	0.000602	0.00983	CbGeAlD
Acetylsalicylic acid—NFKBIA—adrenal gland—breast cancer	0.0006	0.00979	CbGeAlD
Acetylsalicylic acid—TP53—bone marrow—breast cancer	0.00059	0.00963	CbGeAlD
Acetylsalicylic acid—HSPA5—adrenal gland—breast cancer	0.000587	0.00959	CbGeAlD
Acetylsalicylic acid—NFKBIA—bone marrow—breast cancer	0.00058	0.00947	CbGeAlD
Acetylsalicylic acid—RPS6KA3—uterus—breast cancer	0.00057	0.00931	CbGeAlD
Acetylsalicylic acid—TP53—female gonad—breast cancer	0.000568	0.00928	CbGeAlD
Acetylsalicylic acid—HSPA5—bone marrow—breast cancer	0.000568	0.00928	CbGeAlD
Acetylsalicylic acid—RPS6KA3—pituitary gland—breast cancer	0.00056	0.00914	CbGeAlD
Acetylsalicylic acid—NFKBIA—female gonad—breast cancer	0.000559	0.00913	CbGeAlD
Acetylsalicylic acid—RPS6KA3—adipose tissue—breast cancer	0.000558	0.0091	CbGeAlD
Acetylsalicylic acid—HSPA5—female gonad—breast cancer	0.000548	0.00894	CbGeAlD
Acetylsalicylic acid—ALB—mammary gland—breast cancer	0.000534	0.00872	CbGeAlD
Acetylsalicylic acid—TP53—endocrine gland—breast cancer	0.000529	0.00863	CbGeAlD
Acetylsalicylic acid—NFKBIA—endocrine gland—breast cancer	0.00052	0.00849	CbGeAlD
Acetylsalicylic acid—RPS6KA3—female reproductive system—breast cancer	0.000513	0.00837	CbGeAlD
Acetylsalicylic acid—HSPA5—endocrine gland—breast cancer	0.000509	0.00831	CbGeAlD
Acetylsalicylic acid—EDNRA—endometrium—breast cancer	0.000503	0.00821	CbGeAlD
Acetylsalicylic acid—RPS6KA3—adrenal gland—breast cancer	0.0005	0.00817	CbGeAlD
Acetylsalicylic acid—IKBKB—skin of body—breast cancer	0.000485	0.00791	CbGeAlD
Acetylsalicylic acid—RPS6KA3—bone marrow—breast cancer	0.000484	0.0079	CbGeAlD
Acetylsalicylic acid—RPS6KA3—female gonad—breast cancer	0.000466	0.00761	CbGeAlD
Acetylsalicylic acid—EDNRA—uterus—breast cancer	0.000464	0.00757	CbGeAlD
Acetylsalicylic acid—IKBKB—endometrium—breast cancer	0.000457	0.00746	CbGeAlD
Acetylsalicylic acid—EDNRA—pituitary gland—breast cancer	0.000455	0.00743	CbGeAlD
Acetylsalicylic acid—EDNRA—adipose tissue—breast cancer	0.000453	0.0074	CbGeAlD
Acetylsalicylic acid—RPS6KA3—endocrine gland—breast cancer	0.000434	0.00708	CbGeAlD
Acetylsalicylic acid—IKBKB—uterus—breast cancer	0.000421	0.00687	CbGeAlD
Acetylsalicylic acid—IKBKB—pituitary gland—breast cancer	0.000413	0.00675	CbGeAlD
Acetylsalicylic acid—IKBKB—adipose tissue—breast cancer	0.000412	0.00672	CbGeAlD
Acetylsalicylic acid—EDNRA—adrenal gland—breast cancer	0.000407	0.00664	CbGeAlD
Acetylsalicylic acid—EDNRA—female gonad—breast cancer	0.000379	0.00619	CbGeAlD
Acetylsalicylic acid—IKBKB—female reproductive system—breast cancer	0.000378	0.00618	CbGeAlD
Acetylsalicylic acid—CYP2C8—mammary gland—breast cancer	0.000375	0.00613	CbGeAlD
Acetylsalicylic acid—Salicylate-sodium—PTGS1—breast cancer	0.000375	0.2	CrCbGaD
Acetylsalicylic acid—IKBKB—adrenal gland—breast cancer	0.000369	0.00603	CbGeAlD
Acetylsalicylic acid—TP53—lymph node—breast cancer	0.000365	0.00596	CbGeAlD
Acetylsalicylic acid—NFKBIA—lymph node—breast cancer	0.000359	0.00587	CbGeAlD
Acetylsalicylic acid—HSPA5—lymph node—breast cancer	0.000352	0.00575	CbGeAlD
Acetylsalicylic acid—IKBKB—female gonad—breast cancer	0.000344	0.00562	CbGeAlD
Acetylsalicylic acid—CYP2C9—mammary gland—breast cancer	0.000333	0.00544	CbGeAlD
Acetylsalicylic acid—IKBKB—endocrine gland—breast cancer	0.00032	0.00523	CbGeAlD
Acetylsalicylic acid—SLC22A7—endocrine gland—breast cancer	0.000311	0.00507	CbGeAlD
Acetylsalicylic acid—RPS6KA3—lymph node—breast cancer	0.0003	0.0049	CbGeAlD
Acetylsalicylic acid—NFKBIA—Paclitaxel—Docetaxel—breast cancer	0.000287	0.0984	CbGdCrCtD
Acetylsalicylic acid—TP53—Vincristine—Vinorelbine—breast cancer	0.000261	0.0893	CbGdCrCtD
Acetylsalicylic acid—PTGS1—nipple—breast cancer	0.000252	0.00411	CbGeAlD
Acetylsalicylic acid—EDNRA—lymph node—breast cancer	0.000244	0.00398	CbGeAlD
Acetylsalicylic acid—TP53—Testosterone—Exemestane—breast cancer	0.000226	0.0772	CbGdCrCtD
Acetylsalicylic acid—IKBKB—lymph node—breast cancer	0.000221	0.00361	CbGeAlD
Acetylsalicylic acid—Salsalate—PTGS1—breast cancer	0.000219	0.116	CrCbGaD
Acetylsalicylic acid—ALB—adrenal gland—breast cancer	0.000216	0.00352	CbGeAlD
Acetylsalicylic acid—Meclofenamic acid—PTGS1—breast cancer	0.000215	0.115	CrCbGaD
Acetylsalicylic acid—Salicylate-sodium—PTGS2—breast cancer	0.000214	0.114	CrCbGaD
Acetylsalicylic acid—NFKBIA—Doxorubicin—Idarubicin—breast cancer	0.00021	0.0718	CbGdCrCtD
Acetylsalicylic acid—NFKBIA—Epirubicin—Idarubicin—breast cancer	0.00021	0.0718	CbGdCrCtD
Acetylsalicylic acid—NFKBIA—Daunorubicin—Idarubicin—breast cancer	0.00021	0.0718	CbGdCrCtD
Acetylsalicylic acid—TP53—Vincristine—Vinblastine—breast cancer	0.000208	0.0714	CbGdCrCtD
Acetylsalicylic acid—PTGS2—embryo—breast cancer	0.000198	0.00324	CbGeAlD
Acetylsalicylic acid—NFKBIA—Vincristine—Vinorelbine—breast cancer	0.000197	0.0676	CbGdCrCtD
Acetylsalicylic acid—CYP2C8—endometrium—breast cancer	0.000187	0.00306	CbGeAlD
Acetylsalicylic acid—CYP2C8—pituitary gland—breast cancer	0.00017	0.00277	CbGeAlD
Acetylsalicylic acid—PTGS1—epithelium—breast cancer	0.000169	0.00277	CbGeAlD
Acetylsalicylic acid—Mefenamic acid—PTGS1—breast cancer	0.000168	0.0891	CrCbGaD
Acetylsalicylic acid—PTGS2—epithelium—breast cancer	0.000162	0.00264	CbGeAlD
Acetylsalicylic acid—PTGS1—skin of body—breast cancer	0.000161	0.00263	CbGeAlD
Acetylsalicylic acid—NFKBIA—Vincristine—Vinblastine—breast cancer	0.000158	0.0541	CbGdCrCtD
Acetylsalicylic acid—TP53—Testosterone—Fluoxymesterone—breast cancer	0.000156	0.0535	CbGdCrCtD
Acetylsalicylic acid—CYP2C8—female reproductive system—breast cancer	0.000155	0.00253	CbGeAlD
Acetylsalicylic acid—PTGS2—skin of body—breast cancer	0.000154	0.00252	CbGeAlD
Acetylsalicylic acid—PTGS1—endometrium—breast cancer	0.000152	0.00248	CbGeAlD
Acetylsalicylic acid—CYP2C19—endocrine gland—breast cancer	0.000151	0.00246	CbGeAlD
Acetylsalicylic acid—PTGS2—endometrium—breast cancer	0.000145	0.00237	CbGeAlD
Acetylsalicylic acid—PTGS1—uterus—breast cancer	0.00014	0.00229	CbGeAlD
Acetylsalicylic acid—CYP2C9—female reproductive system—breast cancer	0.000138	0.00225	CbGeAlD
Acetylsalicylic acid—PTGS1—pituitary gland—breast cancer	0.000138	0.00225	CbGeAlD
Acetylsalicylic acid—PTGS1—adipose tissue—breast cancer	0.000137	0.00224	CbGeAlD
Acetylsalicylic acid—Salicylic acid—PTGS1—breast cancer	0.000134	0.0715	CrCbGaD
Acetylsalicylic acid—PTGS2—uterus—breast cancer	0.000134	0.00219	CbGeAlD
Acetylsalicylic acid—PTGS2—pituitary gland—breast cancer	0.000131	0.00215	CbGeAlD
Acetylsalicylic acid—CYP2C8—endocrine gland—breast cancer	0.000131	0.00214	CbGeAlD
Acetylsalicylic acid—PTGS2—adipose tissue—breast cancer	0.000131	0.00214	CbGeAlD
Acetylsalicylic acid—ALB—lymph node—breast cancer	0.000129	0.00211	CbGeAlD
Acetylsalicylic acid—TP53—Danazol—Fluoxymesterone—breast cancer	0.000127	0.0435	CbGdCrCtD
Acetylsalicylic acid—PTGS1—female reproductive system—breast cancer	0.000126	0.00206	CbGeAlD
Acetylsalicylic acid—Salsalate—PTGS2—breast cancer	0.000125	0.0665	CrCbGaD
Acetylsalicylic acid—Meclofenamic acid—PTGS2—breast cancer	0.000123	0.0655	CrCbGaD
Acetylsalicylic acid—PTGS1—adrenal gland—breast cancer	0.000123	0.00201	CbGeAlD
Acetylsalicylic acid—ABCB1—embryo—breast cancer	0.000123	0.002	CbGeAlD
Acetylsalicylic acid—PTGS2—female reproductive system—breast cancer	0.00012	0.00196	CbGeAlD
Acetylsalicylic acid—PTGS2—adrenal gland—breast cancer	0.000117	0.00192	CbGeAlD
Acetylsalicylic acid—CYP2C9—endocrine gland—breast cancer	0.000117	0.0019	CbGeAlD
Acetylsalicylic acid—PTGS1—female gonad—breast cancer	0.000115	0.00187	CbGeAlD
Acetylsalicylic acid—TP53—Norethindrone—Fluoxymesterone—breast cancer	0.000114	0.0392	CbGdCrCtD
Acetylsalicylic acid—PTGS2—bone marrow—breast cancer	0.000114	0.00185	CbGeAlD
Acetylsalicylic acid—PTGS2—female gonad—breast cancer	0.000109	0.00179	CbGeAlD
Acetylsalicylic acid—PTGS1—endocrine gland—breast cancer	0.000107	0.00174	CbGeAlD
Acetylsalicylic acid—PTGS2—endocrine gland—breast cancer	0.000102	0.00166	CbGeAlD
Acetylsalicylic acid—ABCB1—epithelium—breast cancer	0.0001	0.00164	CbGeAlD
Acetylsalicylic acid—NFKBIA—Doxorubicin—Epirubicin—breast cancer	9.62e-05	0.033	CbGdCrCtD
Acetylsalicylic acid—NFKBIA—Daunorubicin—Epirubicin—breast cancer	9.62e-05	0.033	CbGdCrCtD
Acetylsalicylic acid—NFKBIA—Idarubicin—Epirubicin—breast cancer	9.62e-05	0.033	CbGdCrCtD
Acetylsalicylic acid—Mefenamic acid—PTGS2—breast cancer	9.58e-05	0.0509	CrCbGaD
Acetylsalicylic acid—ABCB1—endometrium—breast cancer	8.98e-05	0.00147	CbGeAlD
Acetylsalicylic acid—NFKBIA—Epirubicin—Doxorubicin—breast cancer	8.9e-05	0.0305	CbGdCrCtD
Acetylsalicylic acid—NFKBIA—Idarubicin—Doxorubicin—breast cancer	8.9e-05	0.0305	CbGdCrCtD
Acetylsalicylic acid—NFKBIA—Daunorubicin—Doxorubicin—breast cancer	8.9e-05	0.0305	CbGdCrCtD
Acetylsalicylic acid—ABCB1—uterus—breast cancer	8.28e-05	0.00135	CbGeAlD
Acetylsalicylic acid—ABCB1—pituitary gland—breast cancer	8.13e-05	0.00133	CbGeAlD
Acetylsalicylic acid—ABCB1—adipose tissue—breast cancer	8.1e-05	0.00132	CbGeAlD
Acetylsalicylic acid—Salicylic acid—PTGS2—breast cancer	7.69e-05	0.0409	CrCbGaD
Acetylsalicylic acid—ABCB1—female reproductive system—breast cancer	7.44e-05	0.00122	CbGeAlD
Acetylsalicylic acid—PTGS1—lymph node—breast cancer	7.36e-05	0.0012	CbGeAlD
Acetylsalicylic acid—ABCB1—adrenal gland—breast cancer	7.26e-05	0.00119	CbGeAlD
Acetylsalicylic acid—PTGS2—lymph node—breast cancer	7.04e-05	0.00115	CbGeAlD
Acetylsalicylic acid—ABCB1—bone marrow—breast cancer	7.03e-05	0.00115	CbGeAlD
Acetylsalicylic acid—Salicylic acid—ALB—breast cancer	6.85e-05	0.0364	CrCbGaD
Acetylsalicylic acid—ABCB1—female gonad—breast cancer	6.77e-05	0.00111	CbGeAlD
Acetylsalicylic acid—Salicylic acid—ABCB1—breast cancer	6.54e-05	0.0348	CrCbGaD
Acetylsalicylic acid—ABCB1—endocrine gland—breast cancer	6.3e-05	0.00103	CbGeAlD
Acetylsalicylic acid—Dyspnoea—Irinotecan—breast cancer	6.17e-05	0.000632	CcSEcCtD
Acetylsalicylic acid—Somnolence—Irinotecan—breast cancer	6.15e-05	0.00063	CcSEcCtD
Acetylsalicylic acid—Somnolence—Mitoxantrone—breast cancer	6.15e-05	0.00063	CcSEcCtD
Acetylsalicylic acid—Vomiting—Melphalan—breast cancer	6.1e-05	0.000625	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Mitoxantrone—breast cancer	6.09e-05	0.000624	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Irinotecan—breast cancer	6.09e-05	0.000624	CcSEcCtD
Acetylsalicylic acid—Tinnitus—Capecitabine—breast cancer	6.08e-05	0.000622	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Paclitaxel—breast cancer	6.08e-05	0.000622	CcSEcCtD
Acetylsalicylic acid—Gastrointestinal haemorrhage—Doxorubicin—breast cancer	6.07e-05	0.000622	CcSEcCtD
Acetylsalicylic acid—Asthma—Methotrexate—breast cancer	6.06e-05	0.000621	CcSEcCtD
Acetylsalicylic acid—Rash—Melphalan—breast cancer	6.05e-05	0.00062	CcSEcCtD
Acetylsalicylic acid—Flushing—Capecitabine—breast cancer	6.05e-05	0.00062	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Melphalan—breast cancer	6.05e-05	0.00062	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Gemcitabine—breast cancer	6.01e-05	0.000615	CcSEcCtD
Acetylsalicylic acid—Nausea—Vinblastine—breast cancer	5.99e-05	0.000614	CcSEcCtD
Acetylsalicylic acid—Somnolence—Gemcitabine—breast cancer	5.99e-05	0.000614	CcSEcCtD
Acetylsalicylic acid—Convulsion—Paclitaxel—breast cancer	5.99e-05	0.000614	CcSEcCtD
Acetylsalicylic acid—Hypokalaemia—Epirubicin—breast cancer	5.97e-05	0.000612	CcSEcCtD
Acetylsalicylic acid—Hypertension—Paclitaxel—breast cancer	5.97e-05	0.000611	CcSEcCtD
Acetylsalicylic acid—Vomiting—Goserelin—breast cancer	5.95e-05	0.00061	CcSEcCtD
Acetylsalicylic acid—Pruritus—Vinorelbine—breast cancer	5.93e-05	0.000608	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Fluorouracil—breast cancer	5.91e-05	0.000605	CcSEcCtD
Acetylsalicylic acid—Rash—Goserelin—breast cancer	5.9e-05	0.000605	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Thiotepa—breast cancer	5.9e-05	0.000605	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Goserelin—breast cancer	5.9e-05	0.000604	CcSEcCtD
Acetylsalicylic acid—Somnolence—Fluorouracil—breast cancer	5.89e-05	0.000603	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Paclitaxel—breast cancer	5.88e-05	0.000603	CcSEcCtD
Acetylsalicylic acid—Chest pain—Paclitaxel—breast cancer	5.88e-05	0.000603	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Fluorouracil—breast cancer	5.83e-05	0.000597	CcSEcCtD
Acetylsalicylic acid—Nausea—Tamoxifen—breast cancer	5.82e-05	0.000597	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Vinorelbine—breast cancer	5.74e-05	0.000588	CcSEcCtD
Acetylsalicylic acid—Nausea—Melphalan—breast cancer	5.7e-05	0.000584	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Mitoxantrone—breast cancer	5.7e-05	0.000584	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Irinotecan—breast cancer	5.7e-05	0.000584	CcSEcCtD
Acetylsalicylic acid—Confusional state—Paclitaxel—breast cancer	5.69e-05	0.000583	CcSEcCtD
Acetylsalicylic acid—Asthma—Epirubicin—breast cancer	5.67e-05	0.000581	CcSEcCtD
Acetylsalicylic acid—Influenza—Epirubicin—breast cancer	5.67e-05	0.000581	CcSEcCtD
Acetylsalicylic acid—Pruritus—Thiotepa—breast cancer	5.67e-05	0.000581	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Paclitaxel—breast cancer	5.64e-05	0.000578	CcSEcCtD
Acetylsalicylic acid—Nausea—Goserelin—breast cancer	5.56e-05	0.00057	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Gemcitabine—breast cancer	5.55e-05	0.000569	CcSEcCtD
Acetylsalicylic acid—Shock—Paclitaxel—breast cancer	5.55e-05	0.000569	CcSEcCtD
Acetylsalicylic acid—Dizziness—Vinorelbine—breast cancer	5.55e-05	0.000568	CcSEcCtD
Acetylsalicylic acid—Hypokalaemia—Doxorubicin—breast cancer	5.53e-05	0.000566	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Paclitaxel—breast cancer	5.52e-05	0.000566	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Paclitaxel—breast cancer	5.51e-05	0.000564	CcSEcCtD
Acetylsalicylic acid—Urticaria—Mitoxantrone—breast cancer	5.5e-05	0.000563	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Thiotepa—breast cancer	5.48e-05	0.000561	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Fluorouracil—breast cancer	5.46e-05	0.000559	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Paclitaxel—breast cancer	5.45e-05	0.000559	CcSEcCtD
Acetylsalicylic acid—Anaemia—Docetaxel—breast cancer	5.42e-05	0.000555	CcSEcCtD
Acetylsalicylic acid—Drowsiness—Methotrexate—breast cancer	5.4e-05	0.000554	CcSEcCtD
Acetylsalicylic acid—Vomiting—Vinorelbine—breast cancer	5.33e-05	0.000546	CcSEcCtD
Acetylsalicylic acid—Dizziness—Thiotepa—breast cancer	5.3e-05	0.000543	CcSEcCtD
Acetylsalicylic acid—Rash—Vinorelbine—breast cancer	5.29e-05	0.000542	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Vinorelbine—breast cancer	5.28e-05	0.000541	CcSEcCtD
Acetylsalicylic acid—Urticaria—Fluorouracil—breast cancer	5.26e-05	0.000539	CcSEcCtD
Acetylsalicylic acid—Syncope—Docetaxel—breast cancer	5.25e-05	0.000538	CcSEcCtD
Acetylsalicylic acid—Influenza—Doxorubicin—breast cancer	5.25e-05	0.000538	CcSEcCtD
Acetylsalicylic acid—Asthma—Doxorubicin—breast cancer	5.25e-05	0.000538	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Docetaxel—breast cancer	5.24e-05	0.000537	CcSEcCtD
Acetylsalicylic acid—Anaemia—Capecitabine—breast cancer	5.24e-05	0.000537	CcSEcCtD
Acetylsalicylic acid—Sweating—Methotrexate—breast cancer	5.18e-05	0.000531	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Docetaxel—breast cancer	5.15e-05	0.000528	CcSEcCtD
Acetylsalicylic acid—Vertigo—Capecitabine—breast cancer	5.1e-05	0.000522	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Irinotecan—breast cancer	5.1e-05	0.000522	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Mitoxantrone—breast cancer	5.1e-05	0.000522	CcSEcCtD
Acetylsalicylic acid—Vomiting—Thiotepa—breast cancer	5.09e-05	0.000522	CcSEcCtD
Acetylsalicylic acid—Syncope—Capecitabine—breast cancer	5.09e-05	0.000521	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Capecitabine—breast cancer	5.08e-05	0.00052	CcSEcCtD
Acetylsalicylic acid—Convulsion—Docetaxel—breast cancer	5.08e-05	0.00052	CcSEcCtD
Acetylsalicylic acid—Hypertension—Docetaxel—breast cancer	5.06e-05	0.000518	CcSEcCtD
Acetylsalicylic acid—Drowsiness—Epirubicin—breast cancer	5.06e-05	0.000518	CcSEcCtD
Acetylsalicylic acid—Rash—Thiotepa—breast cancer	5.05e-05	0.000517	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Thiotepa—breast cancer	5.05e-05	0.000517	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Paclitaxel—breast cancer	5.03e-05	0.000515	CcSEcCtD
Acetylsalicylic acid—Somnolence—Paclitaxel—breast cancer	5.02e-05	0.000514	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Docetaxel—breast cancer	4.99e-05	0.000511	CcSEcCtD
Acetylsalicylic acid—Chest pain—Docetaxel—breast cancer	4.99e-05	0.000511	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Capecitabine—breast cancer	4.99e-05	0.000511	CcSEcCtD
Acetylsalicylic acid—Nausea—Vinorelbine—breast cancer	4.98e-05	0.00051	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Paclitaxel—breast cancer	4.97e-05	0.000509	CcSEcCtD
Acetylsalicylic acid—Hypertension—Capecitabine—breast cancer	4.9e-05	0.000502	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Fluorouracil—breast cancer	4.88e-05	0.0005	CcSEcCtD
Acetylsalicylic acid—Haemoglobin—Methotrexate—breast cancer	4.88e-05	0.000499	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Methotrexate—breast cancer	4.85e-05	0.000497	CcSEcCtD
Acetylsalicylic acid—Sweating—Epirubicin—breast cancer	4.85e-05	0.000497	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Capecitabine—breast cancer	4.83e-05	0.000495	CcSEcCtD
Acetylsalicylic acid—Chest pain—Capecitabine—breast cancer	4.83e-05	0.000495	CcSEcCtD
Acetylsalicylic acid—Confusional state—Docetaxel—breast cancer	4.82e-05	0.000494	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Docetaxel—breast cancer	4.78e-05	0.00049	CcSEcCtD
Acetylsalicylic acid—Pruritus—Gemcitabine—breast cancer	4.77e-05	0.000488	CcSEcCtD
Acetylsalicylic acid—Nausea—Thiotepa—breast cancer	4.76e-05	0.000487	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Mitoxantrone—breast cancer	4.73e-05	0.000485	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Irinotecan—breast cancer	4.73e-05	0.000485	CcSEcCtD
Acetylsalicylic acid—Shock—Docetaxel—breast cancer	4.7e-05	0.000482	CcSEcCtD
Acetylsalicylic acid—Pruritus—Fluorouracil—breast cancer	4.69e-05	0.00048	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Docetaxel—breast cancer	4.68e-05	0.00048	CcSEcCtD
Acetylsalicylic acid—Drowsiness—Doxorubicin—breast cancer	4.68e-05	0.000479	CcSEcCtD
Acetylsalicylic acid—Confusional state—Capecitabine—breast cancer	4.67e-05	0.000478	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Docetaxel—breast cancer	4.67e-05	0.000478	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Paclitaxel—breast cancer	4.65e-05	0.000476	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Gemcitabine—breast cancer	4.61e-05	0.000472	CcSEcCtD
Acetylsalicylic acid—Dizziness—Irinotecan—breast cancer	4.57e-05	0.000469	CcSEcCtD
Acetylsalicylic acid—Haemoglobin—Epirubicin—breast cancer	4.56e-05	0.000467	CcSEcCtD
Acetylsalicylic acid—Shock—Capecitabine—breast cancer	4.55e-05	0.000467	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Epirubicin—breast cancer	4.54e-05	0.000465	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Fluorouracil—breast cancer	4.53e-05	0.000464	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Capecitabine—breast cancer	4.53e-05	0.000464	CcSEcCtD
Acetylsalicylic acid—Tinnitus—Methotrexate—breast cancer	4.52e-05	0.000463	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Capecitabine—breast cancer	4.52e-05	0.000463	CcSEcCtD
Acetylsalicylic acid—Sweating—Doxorubicin—breast cancer	4.49e-05	0.00046	CcSEcCtD
Acetylsalicylic acid—Urticaria—Paclitaxel—breast cancer	4.48e-05	0.000459	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Capecitabine—breast cancer	4.48e-05	0.000459	CcSEcCtD
Acetylsalicylic acid—Vomiting—Mitoxantrone—breast cancer	4.4e-05	0.000451	CcSEcCtD
Acetylsalicylic acid—Vomiting—Irinotecan—breast cancer	4.4e-05	0.000451	CcSEcCtD
Acetylsalicylic acid—Dizziness—Fluorouracil—breast cancer	4.38e-05	0.000449	CcSEcCtD
Acetylsalicylic acid—Rash—Irinotecan—breast cancer	4.36e-05	0.000447	CcSEcCtD
Acetylsalicylic acid—Rash—Mitoxantrone—breast cancer	4.36e-05	0.000447	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Irinotecan—breast cancer	4.36e-05	0.000446	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Mitoxantrone—breast cancer	4.36e-05	0.000446	CcSEcCtD
Acetylsalicylic acid—ABCB1—lymph node—breast cancer	4.35e-05	0.000711	CbGeAlD
Acetylsalicylic acid—Vomiting—Gemcitabine—breast cancer	4.28e-05	0.000439	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Docetaxel—breast cancer	4.26e-05	0.000437	CcSEcCtD
Acetylsalicylic acid—Somnolence—Docetaxel—breast cancer	4.25e-05	0.000436	CcSEcCtD
Acetylsalicylic acid—Rash—Gemcitabine—breast cancer	4.25e-05	0.000435	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Gemcitabine—breast cancer	4.24e-05	0.000435	CcSEcCtD
Acetylsalicylic acid—Tinnitus—Epirubicin—breast cancer	4.23e-05	0.000434	CcSEcCtD
Acetylsalicylic acid—Haemoglobin—Doxorubicin—breast cancer	4.22e-05	0.000433	CcSEcCtD
Acetylsalicylic acid—Flushing—Epirubicin—breast cancer	4.21e-05	0.000432	CcSEcCtD
Acetylsalicylic acid—Vomiting—Fluorouracil—breast cancer	4.21e-05	0.000432	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Docetaxel—breast cancer	4.21e-05	0.000431	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Doxorubicin—breast cancer	4.2e-05	0.00043	CcSEcCtD
Acetylsalicylic acid—Rash—Fluorouracil—breast cancer	4.18e-05	0.000428	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Fluorouracil—breast cancer	4.17e-05	0.000428	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Paclitaxel—breast cancer	4.16e-05	0.000426	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Capecitabine—breast cancer	4.13e-05	0.000423	CcSEcCtD
Acetylsalicylic acid—Nausea—Irinotecan—breast cancer	4.11e-05	0.000421	CcSEcCtD
Acetylsalicylic acid—Nausea—Mitoxantrone—breast cancer	4.11e-05	0.000421	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Capecitabine—breast cancer	4.08e-05	0.000418	CcSEcCtD
Acetylsalicylic acid—Nausea—Gemcitabine—breast cancer	4e-05	0.00041	CcSEcCtD
Acetylsalicylic acid—Pruritus—Paclitaxel—breast cancer	3.99e-05	0.000409	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Docetaxel—breast cancer	3.94e-05	0.000404	CcSEcCtD
Acetylsalicylic acid—Nausea—Fluorouracil—breast cancer	3.94e-05	0.000403	CcSEcCtD
Acetylsalicylic acid—Tinnitus—Doxorubicin—breast cancer	3.92e-05	0.000401	CcSEcCtD
Acetylsalicylic acid—Anaemia—Methotrexate—breast cancer	3.9e-05	0.0004	CcSEcCtD
Acetylsalicylic acid—Flushing—Doxorubicin—breast cancer	3.9e-05	0.000399	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Paclitaxel—breast cancer	3.86e-05	0.000395	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Capecitabine—breast cancer	3.81e-05	0.000391	CcSEcCtD
Acetylsalicylic acid—Vertigo—Methotrexate—breast cancer	3.79e-05	0.000389	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Methotrexate—breast cancer	3.78e-05	0.000387	CcSEcCtD
Acetylsalicylic acid—Dizziness—Paclitaxel—breast cancer	3.73e-05	0.000382	CcSEcCtD
Acetylsalicylic acid—Urticaria—Capecitabine—breast cancer	3.68e-05	0.000377	CcSEcCtD
Acetylsalicylic acid—Convulsion—Methotrexate—breast cancer	3.66e-05	0.000375	CcSEcCtD
Acetylsalicylic acid—Anaemia—Epirubicin—breast cancer	3.65e-05	0.000374	CcSEcCtD
Acetylsalicylic acid—Agitation—Epirubicin—breast cancer	3.63e-05	0.000372	CcSEcCtD
Acetylsalicylic acid—Chest pain—Methotrexate—breast cancer	3.6e-05	0.000368	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Methotrexate—breast cancer	3.6e-05	0.000368	CcSEcCtD
Acetylsalicylic acid—Vomiting—Paclitaxel—breast cancer	3.59e-05	0.000367	CcSEcCtD
Acetylsalicylic acid—Rash—Paclitaxel—breast cancer	3.56e-05	0.000364	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Paclitaxel—breast cancer	3.55e-05	0.000364	CcSEcCtD
Acetylsalicylic acid—Vertigo—Epirubicin—breast cancer	3.55e-05	0.000364	CcSEcCtD
Acetylsalicylic acid—Syncope—Epirubicin—breast cancer	3.54e-05	0.000363	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Epirubicin—breast cancer	3.54e-05	0.000362	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Docetaxel—breast cancer	3.52e-05	0.000361	CcSEcCtD
Acetylsalicylic acid—Confusional state—Methotrexate—breast cancer	3.47e-05	0.000356	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Epirubicin—breast cancer	3.47e-05	0.000356	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Methotrexate—breast cancer	3.45e-05	0.000353	CcSEcCtD
Acetylsalicylic acid—Convulsion—Epirubicin—breast cancer	3.42e-05	0.000351	CcSEcCtD
Acetylsalicylic acid—Hypertension—Epirubicin—breast cancer	3.41e-05	0.00035	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Capecitabine—breast cancer	3.41e-05	0.000349	CcSEcCtD
Acetylsalicylic acid—Pruritus—Docetaxel—breast cancer	3.38e-05	0.000347	CcSEcCtD
Acetylsalicylic acid—Anaemia—Doxorubicin—breast cancer	3.38e-05	0.000346	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Methotrexate—breast cancer	3.37e-05	0.000346	CcSEcCtD
Acetylsalicylic acid—Chest pain—Epirubicin—breast cancer	3.36e-05	0.000345	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Epirubicin—breast cancer	3.36e-05	0.000345	CcSEcCtD
Acetylsalicylic acid—Agitation—Doxorubicin—breast cancer	3.36e-05	0.000344	CcSEcCtD
Acetylsalicylic acid—Nausea—Paclitaxel—breast cancer	3.35e-05	0.000343	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Methotrexate—breast cancer	3.33e-05	0.000341	CcSEcCtD
Acetylsalicylic acid—Vertigo—Doxorubicin—breast cancer	3.29e-05	0.000337	CcSEcCtD
Acetylsalicylic acid—Syncope—Doxorubicin—breast cancer	3.28e-05	0.000336	CcSEcCtD
Acetylsalicylic acid—Pruritus—Capecitabine—breast cancer	3.28e-05	0.000336	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Doxorubicin—breast cancer	3.27e-05	0.000335	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Docetaxel—breast cancer	3.27e-05	0.000335	CcSEcCtD
Acetylsalicylic acid—Confusional state—Epirubicin—breast cancer	3.25e-05	0.000333	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Epirubicin—breast cancer	3.23e-05	0.00033	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Doxorubicin—breast cancer	3.21e-05	0.000329	CcSEcCtD
Acetylsalicylic acid—Shock—Epirubicin—breast cancer	3.17e-05	0.000325	CcSEcCtD
Acetylsalicylic acid—Convulsion—Doxorubicin—breast cancer	3.17e-05	0.000325	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Capecitabine—breast cancer	3.17e-05	0.000325	CcSEcCtD
Acetylsalicylic acid—Dizziness—Docetaxel—breast cancer	3.16e-05	0.000324	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Epirubicin—breast cancer	3.16e-05	0.000324	CcSEcCtD
Acetylsalicylic acid—Hypertension—Doxorubicin—breast cancer	3.16e-05	0.000323	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Epirubicin—breast cancer	3.15e-05	0.000322	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Epirubicin—breast cancer	3.12e-05	0.000319	CcSEcCtD
Acetylsalicylic acid—Chest pain—Doxorubicin—breast cancer	3.11e-05	0.000319	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Doxorubicin—breast cancer	3.11e-05	0.000319	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Methotrexate—breast cancer	3.07e-05	0.000315	CcSEcCtD
Acetylsalicylic acid—Somnolence—Methotrexate—breast cancer	3.06e-05	0.000314	CcSEcCtD
Acetylsalicylic acid—Dizziness—Capecitabine—breast cancer	3.06e-05	0.000314	CcSEcCtD
Acetylsalicylic acid—Vomiting—Docetaxel—breast cancer	3.04e-05	0.000311	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Methotrexate—breast cancer	3.03e-05	0.000311	CcSEcCtD
Acetylsalicylic acid—Rash—Docetaxel—breast cancer	3.01e-05	0.000309	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Docetaxel—breast cancer	3.01e-05	0.000309	CcSEcCtD
Acetylsalicylic acid—Confusional state—Doxorubicin—breast cancer	3.01e-05	0.000308	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Doxorubicin—breast cancer	2.98e-05	0.000306	CcSEcCtD
Acetylsalicylic acid—Vomiting—Capecitabine—breast cancer	2.94e-05	0.000302	CcSEcCtD
Acetylsalicylic acid—Shock—Doxorubicin—breast cancer	2.94e-05	0.000301	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Doxorubicin—breast cancer	2.92e-05	0.000299	CcSEcCtD
Acetylsalicylic acid—Rash—Capecitabine—breast cancer	2.92e-05	0.000299	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Capecitabine—breast cancer	2.92e-05	0.000299	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Doxorubicin—breast cancer	2.91e-05	0.000298	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Doxorubicin—breast cancer	2.88e-05	0.000296	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Epirubicin—breast cancer	2.88e-05	0.000295	CcSEcCtD
Acetylsalicylic acid—Somnolence—Epirubicin—breast cancer	2.87e-05	0.000294	CcSEcCtD
Acetylsalicylic acid—Nausea—Docetaxel—breast cancer	2.84e-05	0.000291	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Methotrexate—breast cancer	2.84e-05	0.000291	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Epirubicin—breast cancer	2.84e-05	0.000291	CcSEcCtD
Acetylsalicylic acid—Nausea—Capecitabine—breast cancer	2.75e-05	0.000282	CcSEcCtD
Acetylsalicylic acid—Urticaria—Methotrexate—breast cancer	2.74e-05	0.00028	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Doxorubicin—breast cancer	2.66e-05	0.000273	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Epirubicin—breast cancer	2.66e-05	0.000272	CcSEcCtD
Acetylsalicylic acid—Somnolence—Doxorubicin—breast cancer	2.65e-05	0.000272	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Doxorubicin—breast cancer	2.63e-05	0.000269	CcSEcCtD
Acetylsalicylic acid—Urticaria—Epirubicin—breast cancer	2.56e-05	0.000262	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Methotrexate—breast cancer	2.54e-05	0.00026	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Doxorubicin—breast cancer	2.46e-05	0.000252	CcSEcCtD
Acetylsalicylic acid—Pruritus—Methotrexate—breast cancer	2.44e-05	0.00025	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Epirubicin—breast cancer	2.38e-05	0.000243	CcSEcCtD
Acetylsalicylic acid—Urticaria—Doxorubicin—breast cancer	2.37e-05	0.000243	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Methotrexate—breast cancer	2.36e-05	0.000242	CcSEcCtD
Acetylsalicylic acid—Pruritus—Epirubicin—breast cancer	2.28e-05	0.000234	CcSEcCtD
Acetylsalicylic acid—Dizziness—Methotrexate—breast cancer	2.28e-05	0.000233	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Epirubicin—breast cancer	2.21e-05	0.000226	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Doxorubicin—breast cancer	2.2e-05	0.000225	CcSEcCtD
Acetylsalicylic acid—Vomiting—Methotrexate—breast cancer	2.19e-05	0.000224	CcSEcCtD
Acetylsalicylic acid—Rash—Methotrexate—breast cancer	2.17e-05	0.000223	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Methotrexate—breast cancer	2.17e-05	0.000222	CcSEcCtD
Acetylsalicylic acid—Dizziness—Epirubicin—breast cancer	2.13e-05	0.000219	CcSEcCtD
Acetylsalicylic acid—Pruritus—Doxorubicin—breast cancer	2.11e-05	0.000216	CcSEcCtD
Acetylsalicylic acid—Vomiting—Epirubicin—breast cancer	2.05e-05	0.00021	CcSEcCtD
Acetylsalicylic acid—Nausea—Methotrexate—breast cancer	2.05e-05	0.00021	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Doxorubicin—breast cancer	2.04e-05	0.000209	CcSEcCtD
Acetylsalicylic acid—Rash—Epirubicin—breast cancer	2.03e-05	0.000208	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Epirubicin—breast cancer	2.03e-05	0.000208	CcSEcCtD
Acetylsalicylic acid—Dizziness—Doxorubicin—breast cancer	1.97e-05	0.000202	CcSEcCtD
Acetylsalicylic acid—Nausea—Epirubicin—breast cancer	1.92e-05	0.000196	CcSEcCtD
Acetylsalicylic acid—Vomiting—Doxorubicin—breast cancer	1.9e-05	0.000194	CcSEcCtD
Acetylsalicylic acid—Rash—Doxorubicin—breast cancer	1.88e-05	0.000193	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Doxorubicin—breast cancer	1.88e-05	0.000193	CcSEcCtD
Acetylsalicylic acid—Nausea—Doxorubicin—breast cancer	1.77e-05	0.000182	CcSEcCtD
Acetylsalicylic acid—CYP2C19—Metabolism—HSP90AA1—breast cancer	8.37e-07	5.93e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—COMT—breast cancer	8.36e-07	5.92e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—CYP1B1—breast cancer	8.33e-07	5.9e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—APC—breast cancer	8.33e-07	5.9e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—KIT—breast cancer	8.33e-07	5.9e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—VEGFA—breast cancer	8.32e-07	5.89e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—GSTP1—breast cancer	8.32e-07	5.89e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—COMT—breast cancer	8.31e-07	5.88e-06	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—IL6—breast cancer	8.31e-07	5.88e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—MTHFR—breast cancer	8.3e-07	5.88e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Transmembrane transport of small molecules—RAF1—breast cancer	8.28e-07	5.87e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—GSTP1—breast cancer	8.27e-07	5.86e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—EGF—breast cancer	8.23e-07	5.83e-06	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—IL6—breast cancer	8.21e-07	5.81e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—HMOX1—breast cancer	8.2e-07	5.81e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—ITPR1—breast cancer	8.18e-07	5.8e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—STAT3—breast cancer	8.18e-07	5.79e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—IGF1—breast cancer	8.17e-07	5.79e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—AKT2—breast cancer	8.17e-07	5.78e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—HSP90AA1—breast cancer	8.17e-07	5.78e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—HMOX1—breast cancer	8.15e-07	5.78e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—NCOA1—breast cancer	8.14e-07	5.77e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—ITPR1—breast cancer	8.14e-07	5.76e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—NQO1—breast cancer	8.11e-07	5.75e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—SLC2A1—breast cancer	8.11e-07	5.75e-06	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—TP53—breast cancer	8.11e-07	5.74e-06	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—TP53—breast cancer	8.11e-07	5.74e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—STK11—breast cancer	8.02e-07	5.68e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—CYP19A1—breast cancer	8.02e-07	5.68e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	7.95e-07	5.63e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—NCOA1—breast cancer	7.94e-07	5.63e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—CYP3A4—breast cancer	7.91e-07	5.6e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	7.87e-07	5.58e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—MAPK3—breast cancer	7.87e-07	5.58e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—ABCB1—breast cancer	7.87e-07	5.58e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—PIK3CD—breast cancer	7.85e-07	5.56e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—CYP19A1—breast cancer	7.83e-07	5.55e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—STK11—breast cancer	7.83e-07	5.55e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—BRAF—breast cancer	7.83e-07	5.54e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—ABCB1—breast cancer	7.83e-07	5.54e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—MAPK3—breast cancer	7.81e-07	5.53e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—CYP1B1—breast cancer	7.78e-07	5.51e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—SERPINE1—breast cancer	7.76e-07	5.5e-06	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—HRAS—breast cancer	7.76e-07	5.49e-06	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—HRAS—breast cancer	7.76e-07	5.49e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—TYMS—breast cancer	7.73e-07	5.48e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—PIK3CD—breast cancer	7.72e-07	5.47e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—TYMS—breast cancer	7.69e-07	5.44e-06	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—AKT1—breast cancer	7.66e-07	5.43e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—CAV1—breast cancer	7.66e-07	5.42e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—PLA2G4A—breast cancer	7.64e-07	5.41e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—NCOR1—breast cancer	7.64e-07	5.41e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—GSTM1—breast cancer	7.64e-07	5.41e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—TGFB1—breast cancer	7.64e-07	5.41e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—HSP90AA1—breast cancer	7.63e-07	5.4e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—ALB—breast cancer	7.62e-07	5.4e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—AKT2—breast cancer	7.62e-07	5.4e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—GSTM1—breast cancer	7.6e-07	5.38e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—NCOR1—breast cancer	7.6e-07	5.38e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—PLA2G4A—breast cancer	7.6e-07	5.38e-06	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—AKT1—breast cancer	7.57e-07	5.36e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—breast cancer	7.53e-07	5.33e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—COMT—breast cancer	7.46e-07	5.28e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—EGFR—breast cancer	7.43e-07	5.26e-06	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—IL6—breast cancer	7.42e-07	5.26e-06	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—IL6—breast cancer	7.42e-07	5.26e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—GSTP1—breast cancer	7.42e-07	5.26e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—NCOA1—breast cancer	7.42e-07	5.26e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—NOS3—breast cancer	7.41e-07	5.25e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—PIK3CD—breast cancer	7.32e-07	5.18e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—HMOX1—breast cancer	7.32e-07	5.18e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—GPX1—breast cancer	7.32e-07	5.18e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—STK11—breast cancer	7.31e-07	5.18e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—CYP19A1—breast cancer	7.31e-07	5.18e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	7.31e-07	5.18e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—ITPR1—breast cancer	7.3e-07	5.17e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—NOS3—breast cancer	7.29e-07	5.17e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—COMT—breast cancer	7.28e-07	5.16e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—GPX1—breast cancer	7.28e-07	5.15e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—GSTP1—breast cancer	7.24e-07	5.13e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—CYP1A1—breast cancer	7.24e-07	5.13e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—SERPINE1—breast cancer	7.24e-07	5.13e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—CYP1A1—breast cancer	7.2e-07	5.1e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—ERCC2—breast cancer	7.18e-07	5.09e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—HMOX1—breast cancer	7.14e-07	5.06e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—ERCC2—breast cancer	7.14e-07	5.06e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—ITPR1—breast cancer	7.13e-07	5.05e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—KRAS—breast cancer	7.08e-07	5.01e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—MDM2—breast cancer	7.03e-07	4.98e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—ABCB1—breast cancer	7.03e-07	4.98e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—KRAS—breast cancer	7.02e-07	4.97e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—RAF1—breast cancer	7.01e-07	4.96e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—RELA—breast cancer	6.97e-07	4.94e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—PIK3CG—breast cancer	6.97e-07	4.94e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—ERBB2—breast cancer	6.93e-07	4.91e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—NOS3—breast cancer	6.91e-07	4.9e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—TYMS—breast cancer	6.9e-07	4.89e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—breast cancer	6.87e-07	4.86e-06	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—AKT1—breast cancer	6.85e-07	4.85e-06	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—AKT1—breast cancer	6.85e-07	4.85e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—MTOR—breast cancer	6.84e-07	4.84e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—PIK3CB—breast cancer	6.84e-07	4.84e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—NCOR1—breast cancer	6.82e-07	4.83e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—GSTM1—breast cancer	6.82e-07	4.83e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—PLA2G4A—breast cancer	6.82e-07	4.83e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—COMT—breast cancer	6.8e-07	4.82e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—GSTP1—breast cancer	6.77e-07	4.79e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—MTHFR—breast cancer	6.75e-07	4.78e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—TYMS—breast cancer	6.74e-07	4.77e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—PIK3CB—breast cancer	6.73e-07	4.77e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—MTHFR—breast cancer	6.72e-07	4.76e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—HMOX1—breast cancer	6.67e-07	4.73e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—PTGS2—breast cancer	6.67e-07	4.72e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—ITPR1—breast cancer	6.66e-07	4.72e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—GSTM1—breast cancer	6.66e-07	4.72e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—PLA2G4A—breast cancer	6.66e-07	4.72e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—NCOR1—breast cancer	6.66e-07	4.72e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CXCL8—breast cancer	6.57e-07	4.66e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—MDM2—breast cancer	6.56e-07	4.64e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—RAF1—breast cancer	6.54e-07	4.63e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—GPX1—breast cancer	6.53e-07	4.63e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—PIK3CA—breast cancer	6.5e-07	4.6e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—CYP1A1—breast cancer	6.47e-07	4.58e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—ERBB2—breast cancer	6.47e-07	4.58e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—PIK3CA—breast cancer	6.45e-07	4.57e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CDKN1B—breast cancer	6.42e-07	4.55e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—ERCC2—breast cancer	6.41e-07	4.54e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—ABCB1—breast cancer	6.41e-07	4.54e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—PIK3CB—breast cancer	6.38e-07	4.52e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—MTOR—breast cancer	6.38e-07	4.52e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—GPX1—breast cancer	6.38e-07	4.52e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—CD4—breast cancer	6.37e-07	4.51e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—CYP1A1—breast cancer	6.31e-07	4.47e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—TYMS—breast cancer	6.29e-07	4.46e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CASP3—breast cancer	6.29e-07	4.46e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—TP53—breast cancer	6.29e-07	4.45e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—IL2—breast cancer	6.28e-07	4.45e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—ERCC2—breast cancer	6.26e-07	4.43e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—CAV1—breast cancer	6.23e-07	4.41e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—PLA2G4A—breast cancer	6.22e-07	4.41e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—GSTM1—breast cancer	6.22e-07	4.41e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—NCOR1—breast cancer	6.22e-07	4.41e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—CAV1—breast cancer	6.19e-07	4.39e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—PIK3CD—breast cancer	6.13e-07	4.34e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CCND1—breast cancer	6.12e-07	4.34e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—JUN—breast cancer	6.11e-07	4.33e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CTNNB1—breast cancer	6.06e-07	4.3e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—ALB—breast cancer	6.05e-07	4.29e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—MTHFR—breast cancer	6.03e-07	4.27e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—HRAS—breast cancer	6.01e-07	4.26e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—CDKN1B—breast cancer	5.99e-07	4.24e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—HRAS—breast cancer	5.97e-07	4.23e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—GPX1—breast cancer	5.96e-07	4.22e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	5.95e-07	4.22e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—MMP9—breast cancer	5.95e-07	4.21e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CDKN1A—breast cancer	5.92e-07	4.2e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	5.92e-07	4.19e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—PTEN—breast cancer	5.91e-07	4.19e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—CYP1A1—breast cancer	5.9e-07	4.18e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—MTHFR—breast cancer	5.88e-07	4.17e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—ERCC2—breast cancer	5.85e-07	4.14e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—PTEN—breast cancer	5.82e-07	4.12e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—NOS3—breast cancer	5.79e-07	4.1e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—MAPK8—breast cancer	5.78e-07	4.1e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—IL6—breast cancer	5.71e-07	4.04e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—PIK3CG—breast cancer	5.67e-07	4.02e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—CTNNB1—breast cancer	5.66e-07	4.01e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—PIK3CG—breast cancer	5.64e-07	4e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—CAV1—breast cancer	5.56e-07	3.94e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—CDKN1A—breast cancer	5.53e-07	3.91e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—PTEN—breast cancer	5.51e-07	3.91e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—MTHFR—breast cancer	5.5e-07	3.89e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—SRC—breast cancer	5.48e-07	3.88e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—CAV1—breast cancer	5.43e-07	3.84e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—PIK3CB—breast cancer	5.34e-07	3.78e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—VEGFA—breast cancer	5.34e-07	3.78e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	5.31e-07	3.76e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—AKT1—breast cancer	5.31e-07	3.76e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—STAT3—breast cancer	5.29e-07	3.74e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—AKT1—breast cancer	5.27e-07	3.73e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—SRC—breast cancer	5.11e-07	3.62e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—CAV1—breast cancer	5.07e-07	3.59e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—PIK3CG—breast cancer	5.06e-07	3.59e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—MAPK3—breast cancer	5.05e-07	3.58e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—PIK3CD—breast cancer	4.99e-07	3.53e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—PIK3CD—breast cancer	4.96e-07	3.51e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—PIK3CG—breast cancer	4.94e-07	3.5e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—STAT3—breast cancer	4.93e-07	3.49e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—ALB—breast cancer	4.92e-07	3.49e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—MYC—breast cancer	4.91e-07	3.48e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—TGFB1—breast cancer	4.9e-07	3.47e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	4.84e-07	3.43e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—EGFR—breast cancer	4.8e-07	3.4e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—MAPK3—breast cancer	4.71e-07	3.34e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—NOS3—breast cancer	4.71e-07	3.34e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—NOS3—breast cancer	4.68e-07	3.32e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—PIK3CG—breast cancer	4.62e-07	3.27e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—PTEN—breast cancer	4.62e-07	3.27e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—MYC—breast cancer	4.58e-07	3.25e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—TGFB1—breast cancer	4.57e-07	3.24e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—KRAS—breast cancer	4.54e-07	3.21e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—EGFR—breast cancer	4.48e-07	3.17e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—PIK3CD—breast cancer	4.45e-07	3.15e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—ALB—breast cancer	4.4e-07	3.11e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—PIK3CB—breast cancer	4.35e-07	3.08e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—PIK3CD—breast cancer	4.35e-07	3.08e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—PIK3CB—breast cancer	4.32e-07	3.06e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—PTGS2—breast cancer	4.31e-07	3.05e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—ALB—breast cancer	4.29e-07	3.04e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—PTGS2—breast cancer	4.28e-07	3.03e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—KRAS—breast cancer	4.23e-07	3e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—NOS3—breast cancer	4.2e-07	2.98e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—PIK3CA—breast cancer	4.17e-07	2.95e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—NOS3—breast cancer	4.1e-07	2.91e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—PIK3CA—breast cancer	4.1e-07	2.91e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—PIK3CD—breast cancer	4.06e-07	2.88e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—TP53—breast cancer	4.03e-07	2.86e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—ALB—breast cancer	4.01e-07	2.84e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—PIK3CA—breast cancer	3.89e-07	2.75e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—PIK3CB—breast cancer	3.88e-07	2.75e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—HRAS—breast cancer	3.86e-07	2.73e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—PTGS2—breast cancer	3.85e-07	2.72e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—NOS3—breast cancer	3.83e-07	2.72e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—PIK3CB—breast cancer	3.79e-07	2.68e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—PTEN—breast cancer	3.76e-07	2.66e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—PTGS2—breast cancer	3.75e-07	2.66e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—PTEN—breast cancer	3.74e-07	2.65e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—IL6—breast cancer	3.69e-07	2.62e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—HRAS—breast cancer	3.6e-07	2.55e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—PIK3CB—breast cancer	3.54e-07	2.51e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—PTGS2—breast cancer	3.51e-07	2.48e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—IL6—breast cancer	3.44e-07	2.44e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—AKT1—breast cancer	3.41e-07	2.41e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—PTEN—breast cancer	3.35e-07	2.38e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—AKT1—breast cancer	3.35e-07	2.37e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—PTEN—breast cancer	3.27e-07	2.32e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—PIK3CA—breast cancer	3.26e-07	2.31e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—AKT1—breast cancer	3.18e-07	2.25e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—PTEN—breast cancer	3.06e-07	2.17e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—AKT1—breast cancer	2.66e-07	1.88e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—PIK3CA—breast cancer	2.65e-07	1.88e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—PIK3CA—breast cancer	2.64e-07	1.87e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—PIK3CA—breast cancer	2.37e-07	1.68e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—PIK3CA—breast cancer	2.31e-07	1.64e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—AKT1—breast cancer	2.17e-07	1.53e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—PIK3CA—breast cancer	2.16e-07	1.53e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—AKT1—breast cancer	2.15e-07	1.52e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—AKT1—breast cancer	1.93e-07	1.37e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—AKT1—breast cancer	1.89e-07	1.34e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—AKT1—breast cancer	1.76e-07	1.25e-06	CbGpPWpGaD
